Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
218
-
Total 13F shares, excl. options
-
50.2M
-
Shares change
-
+1.35M
-
Total reported value, excl. options
-
$1.51B
-
Value change
-
+$39.7M
-
Put/Call ratio
-
1.28
-
Number of buys
-
108
-
Number of sells
-
-92
-
Price
-
$30.17
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q2 2024
242 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q2 2024.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 218 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.2M shares
of 57.1M outstanding shares and own 87.83% of the company stock.
Largest 10 shareholders include Valor Management LLC (11.2M shares), BlackRock Inc. (5.84M shares), FMR LLC (5.24M shares), VANGUARD GROUP INC (3.52M shares), Vivo Capital, LLC (2.61M shares), Pacer Advisors, Inc. (2.51M shares), STATE STREET CORP (1.27M shares), venBio Partners LLC (1.04M shares), DIMENSIONAL FUND ADVISORS LP (957K shares), and MORGAN STANLEY (836K shares).
This table shows the top 218 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.